Pozen: ROTH Conference (Pozen) - Mar 20, 2013 - Anticipated patent expiry in US for secondary prevention of cardiovascular disease in patients at risk for aspirin-induced ulcers on Feb 28, 2023; Anticipated patent protection for secondary prevention of cardiovascular disease in patients at risk for aspirin-induced ulcers through 2032
Anticipated patent • Anticipated patent expiry • Acute Coronary Syndrome
|